<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000540457"><TermName>fluorine F 18 FEQA</TermName><TermPronunciation>(FLOOR-een …)</TermPronunciation><TermDefinition><DefinitionText>A radioactive substance being studied in positron emission tomography (PET) imaging to detect cancer and to monitor the response of some types of cancer to treatment. Fluorine F 18 FEQA attaches to the epidermal growth factor receptor (EGFR) found on the surface of some tumor cells. It is a type of radiopharmaceutical.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718733" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fluorine F 18 FEQA&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718732" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;flúor F 18 FEQA&quot;" language="es" id="_4"/><SpanishTermName>flúor F 18 FEQA</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia radiactiva que se estudia en la tomografía por emisión de positrones (TEP) para detectar el cáncer y vigilar la respuesta de algunos tipos de cáncer al tratamiento. El flúor F 18 FEQA se acopla al receptor del factor de crecimiento epidérmico (RFCE) que se encuentra en la superficie de algunas células tumorales. Es un tipo de radiofármaco.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-04</DateFirstPublished></GlossaryTerm>
